As of Feb 23
| +0.01 / +0.42%|
The 5 analysts offering 12-month price forecasts for Celldex Therapeutics Inc have a median target of 9.00, with a high estimate of 10.00 and a low estimate of 3.50. The median estimate represents a +279.75% increase from the last price of 2.37.
The current consensus among 7 polled investment analysts is to Buy stock in Celldex Therapeutics Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.